PapersFlow Research Brief
Paraoxonase enzyme and polymorphisms
Research Guide
What is Paraoxonase enzyme and polymorphisms?
Paraoxonase enzymes are a family of proteins associated with high-density lipoproteins (HDL) that exhibit antioxidant properties by inhibiting lipid peroxidation and protecting against atherosclerosis, with genetic polymorphisms influencing their enzyme activity and association with cardiovascular diseases.
Paraoxonase (PON) enzymes, particularly PON1, are linked to HDL and prevent the oxidation of low-density lipoprotein (LDL), reducing monocyte-endothelial interactions that contribute to atherosclerosis. There are 9,635 papers on paraoxonase enzyme and polymorphisms. Research demonstrates that PON inhibits HDL oxidation and preserves its anti-atherogenic functions, with PON deficiency increasing susceptibility to organophosphate toxicity and atherosclerosis.
Topic Hierarchy
Research Sub-Topics
Paraoxonase Genetic Polymorphisms
This sub-topic studies PON1, PON2, PON3 gene variants, allele frequencies, and their functional impacts on enzyme activity. Researchers associate polymorphisms with disease susceptibility using genotyping.
Paraoxonase and Atherosclerosis
This sub-topic investigates PON's protective role against oxidized LDL, plaque formation, and vascular inflammation. Researchers use knockout models and human cohorts to link PON deficiency to disease.
Paraoxonase HDL Association
This sub-topic examines PON binding to HDL, anti-inflammatory properties, and preservation of HDL functions during oxidative stress. Researchers study PON's role in reversing pro-inflammatory HDL.
Paraoxonase Enzyme Activity Assays
This sub-topic develops and validates assays for arylesterase, lactonase, and paraoxonase activities influenced by substrates and inhibitors. Researchers correlate activity levels with clinical outcomes.
Paraoxonase Oxidative Stress Inhibition
This sub-topic explores PON inhibition of lipid peroxidation, lipoperoxide accumulation, and cellular oxidative damage. Researchers elucidate mechanisms in LDL and HDL contexts.
Why It Matters
Paraoxonase enzymes protect against atherosclerosis by inhibiting the biological activity of minimally oxidized LDL, as shown in studies where HDL-associated PON blocked monocyte-endothelial interactions induced by mildly oxidized LDL (Watson et al., 1995, "Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein."). In PON1-knockout mice, absence of serum PON led to increased atherosclerosis and organophosphate toxicity (Shih et al., 1998, "Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis"). PON also preserves HDL functions by preventing its oxidation, supporting HDL's role in cholesterol efflux and anti-inflammatory effects relevant to cardiovascular disease prevention (Aviram et al., 1998, "Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase."). These findings highlight PON's therapeutic potential in managing oxidative stress and lipid peroxidation in clinical settings.
Reading Guide
Where to Start
"Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein." by Watson et al. (1995) because it directly demonstrates PON's core protective role against oxidized LDL in a foundational experiment on monocyte interactions.
Key Papers Explained
Watson et al. (1995, "Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein.") established HDL-PON's inhibition of minimally oxidized LDL activity, which Aviram et al. (1998, "Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.") extended to HDL protection and function preservation. Shih et al. (1998, "Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis") provided genetic validation via PON-knockout mice, linking deficiency to disease. Barter et al. (2004, "Antiinflammatory Properties of HDL") contextualizes PON within broader HDL anti-atherogenic mechanisms.
Paper Timeline
Most-cited paper highlighted in red. Papers ordered chronologically.
Advanced Directions
Research emphasizes paraoxonase's integration with HDL in oxidative stress and inflammation pathways, as explored in Biswas (2016, "Does the Interdependence between Oxidative Stress and Inflammation Explain the Antioxidant Paradox?"), questioning antioxidant trial failures. No recent preprints or news available, so frontiers remain in genetic polymorphism effects on enzyme activity and cardiovascular outcomes.
Papers at a Glance
Frequently Asked Questions
What is the role of paraoxonase in protecting against LDL oxidation?
Paraoxonase associated with HDL inhibits the biological activity of minimally oxidized LDL, preventing monocyte-endothelial interactions that promote atherosclerosis. Watson et al. (1995) demonstrated this protective effect in studies using lipoxygenase-oxidized LDL. This mechanism reduces the pro-atherogenic potential of oxidized lipids.
How does paraoxonase activity affect HDL function?
Paraoxonase prevents HDL oxidation, preserving its anti-atherogenic properties such as cholesterol efflux. Aviram et al. (1998) showed that PON associated with HDL inhibits lipid peroxidation in HDL particles. Human serum studies confirmed higher PON activity correlates with reduced HDL oxidation susceptibility.
What happens in the absence of serum paraoxonase?
Mice lacking serum paraoxonase develop increased atherosclerosis and are more susceptible to organophosphate toxicity. Shih et al. (1998) reported that PON1-knockout mice exhibited these phenotypes compared to wild-type controls. This underscores PON's role in antioxidant defense and cardiovascular protection.
What are the anti-inflammatory properties of HDL related to paraoxonase?
HDL's anti-inflammatory effects include protection against atherosclerosis via cholesterol efflux, with paraoxonase contributing to inhibition of oxidized lipid effects. Barter et al. (2004) outlined HDL functions that minimize cholesterol accumulation in arteries. Paraoxonase enhances these by preventing LDL and HDL oxidation.
How do genetic polymorphisms influence paraoxonase?
Genetic polymorphisms in paraoxonase genes affect enzyme activity levels, impacting protection against oxidative stress and cardiovascular risk. Studies link PON1 variants to altered hydrolysis of organophosphates and lipid peroxides. This variability explains differences in atherosclerosis susceptibility across populations.
Open Research Questions
- ? How do specific paraoxonase polymorphisms quantitatively alter enzyme activity in human HDL and affect atherosclerosis progression?
- ? What mechanisms link paraoxonase deficiency to increased organophosphate toxicity beyond atherosclerosis?
- ? Can paraoxonase modulation enhance HDL's anti-inflammatory effects in clinical cardiovascular interventions?
- ? How does paraoxonase interact with oxidative stress pathways in inflammation-dependent diseases?
- ? What are the structural bases of paraoxonase polymorphisms influencing lipid peroxidation inhibition?
Recent Trends
The field encompasses 9,635 works with sustained focus on paraoxonase's role in atherosclerosis, oxidative stress, and HDL protection, as evidenced by highly cited papers like Aviram et al. (1998, 1147 citations) and Shih et al. (1998, 1081 citations).
No growth rate data over 5 years or recent preprints/news reported, indicating stable interest without new accelerations.
Research Paraoxonase enzyme and polymorphisms with AI
PapersFlow provides specialized AI tools for Biochemistry, Genetics and Molecular Biology researchers. Here are the most relevant for this topic:
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Paper Summarizer
Get structured summaries of any paper in seconds
Deep Research Reports
Multi-source evidence synthesis with counter-evidence
See how researchers in Life Sciences use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Paraoxonase enzyme and polymorphisms with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Biochemistry, Genetics and Molecular Biology researchers